Cargando…
A Conserved Target Site in HIV-1 Gag RNA is Accessible to Inhibition by Both an HDV Ribozyme and a Short Hairpin RNA
Antisense-based molecules targeting HIV-1 RNA have the potential to be used as part of gene or drug therapy to treat HIV-1 infection. In this study, HIV-1 RNA was screened to identify more conserved and accessible target sites for ribozymes based on the hepatitis delta virus motif. Using a quantitat...
Autores principales: | Scarborough, Robert J, Lévesque, Michel V, Boudrias-Dalle, Etienne, Chute, Ian C, Daniels, Sylvanne M, Ouellette, Rodney J, Perreault, Jean-Pierre, Gatignol, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121520/ https://www.ncbi.nlm.nih.gov/pubmed/25072692 http://dx.doi.org/10.1038/mtna.2014.31 |
Ejemplares similares
-
Towards gene therapy against HIV-1: new therapeutic target in gag RNA accessible to ribozymes and RNA interference molecules
por: Gatignol, A, et al.
Publicado: (2014) -
Inhibition of HIV-1 expression and replication by SOFA-HDV ribozymes against Tat and Rev mRNA sequences
por: Lainé, Sébastien, et al.
Publicado: (2009) -
Characterization of the Trans Watson-Crick
GU Base Pair Located in the Catalytic Core of the Antigenomic HDV Ribozyme
por: Lévesque, Dominique, et al.
Publicado: (2012) -
The poly(A) site sequence in HDV RNA alters both extent and rate of self-cleavage of the antigenomic ribozyme
por: Brown, Abigail L., et al.
Publicado: (2008) -
Inhibition of telomerase activity by HDV ribozyme in cancers
por: Lu, Yingying, et al.
Publicado: (2011)